Market Downturn: Replimune Group, Inc. (NASDAQ: REPL) Leads Stock Declines Amid Regulatory Setbacks and Earnings Misses
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameReplimune Group, Inc.
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









